Creo Medical Group PLC (AIM:CREO)

Market Cap	41.76M
Revenue (ttm)	4.60M
Net Income (ttm)	500.00K
Shares Out	402.47M
EPS (ttm)	-0.00
PE Ratio	47.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,735,266
Average Volume	908,706
Open	10.25
Previous Close	10.13
Day's Range	10.00 - 10.62
52-Week Range	9.22 - 22.50
Beta	0.39
RSI	45.42
Earnings Date	Dec 23, 2025

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 129
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.